| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/09/2009 | US20090176319 Calibrator For Immunoassays |
| 07/09/2009 | US20090176318 Binary dna probe for fluorescent analysis of nucleic acids |
| 07/09/2009 | US20090176317 Soluble B7-H1 |
| 07/09/2009 | US20090176311 Separation of conjugated and unconjugated components |
| 07/09/2009 | US20090176310 Using matrix independent turbidimetry to determine fibrinogen concentration and diagnose/prognose atherothrombotic diseases; based on a measurement of turbidity |
| 07/09/2009 | US20090176309 Fluorescent Assay |
| 07/09/2009 | US20090176279 Bioreactive agents |
| 07/09/2009 | US20090176274 Glycosylated mammalian ngal and use thereof |
| 07/09/2009 | US20090176271 Systems for Efficient Staining and Sorting of Populations of Cells |
| 07/09/2009 | US20090176261 Method of determining the point at which coagulating blood forms a clot |
| 07/09/2009 | US20090176259 Methods for detection of botulinum neurotoxin |
| 07/09/2009 | US20090176258 Test for the detection of pathological prions |
| 07/09/2009 | US20090176257 Methods and Biomarkers for Diagnosing and Monitoring Psychotic Disorders |
| 07/09/2009 | US20090176256 Methods and Products for Evaluating an Immune Response to a Therapeutic Protein |
| 07/09/2009 | US20090176255 Immunomagnetic capture and imaging of biological targets |
| 07/09/2009 | US20090176254 Mammalian galanin receptors |
| 07/09/2009 | US20090176253 Antibody conjugates |
| 07/09/2009 | US20090176252 Method for the Measurement of Endocrine Substances In an Analyte |
| 07/09/2009 | US20090176251 Methods for Diagnosing Celiac Disease Based on the Level of Anti-Gliadin and Anti-tTG IgA and IgG Antibodies |
| 07/09/2009 | US20090176250 Immunoliposome-Nucleic Acid Amplification (ILNAA) Assay |
| 07/09/2009 | US20090176249 Method for detecting cardiac collateral formation |
| 07/09/2009 | US20090176248 Method For Evaluating Kidney Function In A Feline |
| 07/09/2009 | US20090176247 Determination of sFlt-1:Angiogenic Factor Complex |
| 07/09/2009 | US20090176246 ASSAY FOR MEASURING FACTOR VIIa-ANTITHROMBIN COMPLEXES |
| 07/09/2009 | US20090176245 Rheumatoid Arthritis Test Method and Treating Method |
| 07/09/2009 | US20090176244 Methods and compositions for the diagnosis of crohn's disease |
| 07/09/2009 | US20090176243 Novel monkey GPR103 and monkey QRFP and method of evaluating compound by using GPR103 |
| 07/09/2009 | US20090176240 MN/CA IX and Cancer Prognosis |
| 07/09/2009 | US20090176235 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 07/09/2009 | US20090176230 Microfluidic device and methods of using same |
| 07/09/2009 | US20090176228 Lung cancer markers, and uses thereof |
| 07/09/2009 | US20090176223 Compositions, Kits, and Methods for the Diagnosis, Prognosis, and Monitoring of Immune Disorders Using Galectin-1 |
| 07/09/2009 | US20090176221 Method of detecting an analyte in a sample using semiconductor nanocrystals as detectable label |
| 07/09/2009 | US20090176217 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 07/09/2009 | US20090176215 Gene methylation in prostate cancer diagnosis |
| 07/09/2009 | US20090176214 Recombinant antigens for the detection of Coxiella burnetii |
| 07/09/2009 | US20090176213 a dry assay reagent, which comprises a solid support and one or more molecules of a receptor immobilized on the solid support; bioassay |
| 07/09/2009 | US20090176210 Microbial reductive dehalogenation of vinyl chloride |
| 07/09/2009 | US20090176205 Mutant proteins in the dna-binding domain of a telomeric protein, trf2, and telomeric dna mutants, and use of the complex structure of the trf2 dna-binding domain and telomeric dna |
| 07/09/2009 | US20090176204 Method for improved diagnosis of dysplasias |
| 07/09/2009 | US20090176201 Microbubbles for affinity separation |
| 07/09/2009 | US20090175895 Methods and compositions for treating and preventing malaria |
| 07/09/2009 | US20090175887 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 07/09/2009 | US20090175885 Method of controlling insect pests in cotton |
| 07/09/2009 | US20090175884 Misfolded proteins in cancer treatment and diagnosis |
| 07/09/2009 | US20090175880 Antibodies that bind human dendritic and epithelial cell 205 (dec-205) |
| 07/09/2009 | US20090175877 Methods of inhibiting metastasis |
| 07/09/2009 | US20090175871 Method for demonstrating presence or absence of markers associated with the presence and/or the chemosensitivity of tumors |
| 07/09/2009 | US20090175867 Single-Chain Multivalent Binding Proteins with Effector Function |
| 07/09/2009 | US20090175860 Compositions and Methods of Use for Antibodies of c-Met |
| 07/09/2009 | US20090175858 Crystalline EGFR - matuzumab complex and matuzumab mimetics obtained thereof |
| 07/09/2009 | US20090175855 Novel compositions and methods for the treatment of immune related diseases |
| 07/09/2009 | US20090175850 NOGO Receptor Homologs |
| 07/09/2009 | US20090175847 Humanized antibodies to ab (20-42) globulomer and uses thereof |
| 07/09/2009 | US20090175819 Molecule and chimeric molecules thereof |
| 07/09/2009 | US20090175800 Methods and Compositions For P2X Receptor Calcium Entry Channels and Other Calcium Entry Mechanisms |
| 07/09/2009 | US20090175796 Antibodies and related molecules that bind to 24p4c12 proteins |
| 07/09/2009 | US20090175793 Treatment of male sexual dysfunction |
| 07/09/2009 | US20090175791 Anti-VEGF Antibody Compositions and Methods |
| 07/09/2009 | US20090175789 Antibody raised against the ldl receptor |
| 07/09/2009 | US20090175529 Method and apparatus for selectively targeting specific cells within a cell population |
| 07/09/2009 | US20090174878 Optical measurement device |
| 07/09/2009 | US20090173640 Electronic methods for the detection of analytes |
| 07/09/2009 | US20090173631 Single Cell Analysis of Membrane Molecules |
| 07/09/2009 | US20090173629 Multiparameter system for environmental monitoring |
| 07/09/2009 | US20090173172 System and method for generating a gas sample of known and adjustable relative humidity |
| 07/09/2009 | US20090173145 Apparatus and method for determining analyte content in a fluid |
| 07/09/2009 | DE102007030865A1 Vorrichtung und Verfahren zum Scannen von Massivhölzern Apparatus and method for scanning solid woods |
| 07/09/2009 | CA2710761A1 Anti-t. cruzi antibodies and methods of use |
| 07/09/2009 | CA2710681A1 Detection method and determination method for detection target |
| 07/09/2009 | CA2710586A1 Detection method and determination method for detection target |
| 07/09/2009 | CA2710518A1 Method and compositions for specifically detecting physiologically acceptable polymer molecules |
| 07/09/2009 | CA2710516A1 Methods and devices for simultaneously detecting ozone and carbonyl-containing compounds |
| 07/09/2009 | CA2710395A1 Method for predicting responsiveness to a pharmaceutical therapy for obesity |
| 07/09/2009 | CA2710333A1 Predicting long-term efficacy of a compound in the treatment of psoriasis |
| 07/09/2009 | CA2710248A1 Methods, systems and computer program products for predicting responsiveness to a pharmaceutical therapy for obesity or evaluating investigational pharmaceutical agents |
| 07/09/2009 | CA2710195A1 Allelic discrimination analysis using an efficiency related value (efr) |
| 07/09/2009 | CA2709678A1 Use of activating transcription factor-2 (atf2) for detecting skin cancer |
| 07/09/2009 | CA2709073A1 Methods for differentiating plasma-derived protein from recombinant protein in a sample |
| 07/09/2009 | CA2701447A1 Methods of using and constructing nanosensor platforms |
| 07/08/2009 | EP2077445A1 Method for identifying abnormal state, analytical apparatus, and reagent |
| 07/08/2009 | EP2077444A2 Chromatography quantitative measuring apparatus |
| 07/08/2009 | EP2077443A2 Chromatography quantitative measuring apparatus |
| 07/08/2009 | EP2077333A1 Method for quantification of cholesterol in small dense low-density lipoprotein |
| 07/08/2009 | EP2077331A1 METHOD FOR EVALUATING COMPOUND USING PKC-iota |
| 07/08/2009 | EP2077328A1 Platelet aggregation inhibitor composition |
| 07/08/2009 | EP2077325A1 Monoclonal antibody and use thereof |
| 07/08/2009 | EP2077324A2 Genes encoding proteolytic enzymes from aspargilli |
| 07/08/2009 | EP2077280A2 Anti-Carbohydrate Deficient Transferrin (CDT) specific antibodies, their production and use |
| 07/08/2009 | EP2077279A1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 07/08/2009 | EP2077277A1 Use of mammalian cytokine; related reagents |
| 07/08/2009 | EP2077275A2 IgA nephropathy-related DNA |
| 07/08/2009 | EP2077272A1 Polypeptide libraries with a predetermined scaffold |
| 07/08/2009 | EP2077115A1 Platelet-rich plasma separator and platelet-rich plasma separation method |
| 07/08/2009 | EP2076785A2 Magnetic sensor device with reference unit |
| 07/08/2009 | EP2076779A1 Biomarker for mitochondrial toxicity associated with phospholipidosis |
| 07/08/2009 | EP2076778A2 Organic compounds |
| 07/08/2009 | EP2076777A2 Method for detecting il-16 activity and modulation of il-16 activity based on phosphorylated stat-6 proxy levels |
| 07/08/2009 | EP2076776A2 Autoantigens for improved diagnosis, prognosis and treatment of inflammatory neurological diseases |
| 07/08/2009 | EP2076775A2 Lateral flow and flow-through bioassay based on patterned porous media, methods of making same, and methods of using same |